Biomarkers in Patients Undergoing Transrectal Ultrasound Prostate Biopsy
Completed
Conditions studied: Prostate Cancer
In brief
RATIONALE: Collecting and storing samples of blood and urine from patients with cancer to study in the laboratory may help doctors learn more about changes that may occur in DNA and identify biomarkers related to cancer. PURPOSE: This laboratory study is looking at biomarkers in patients undergoing transrectal ultrasound prostate biopsy.
Key facts
- Study ID
- NCT00373035
- Run by
- Wake Forest University Health Sciences
- People needed
- 60
- Starts
- 2006-02-01
- Last updated by the study team
- 2017-01-19
Who can join
Age: 18 and older, up to 120. Sex: male. Healthy volunteers: not accepted.
Where it is running
- SurroMed Incorporated — Menlo Park, California, United States
- Wake Forest University Comprehensive Cancer Center — Winston-Salem, North Carolina, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.